LENZ Therapeutics, Inc.
LENZ
$28.00
$0.692.53%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -16.70M | -14.91M | -14.62M | -12.65M | -10.22M |
| Total Depreciation and Amortization | 125.00K | 19.00K | 36.00K | 25.00K | 10.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.69M | 1.96M | 1.50M | 222.00K | 832.00K |
| Change in Net Operating Assets | 5.30M | 1.43M | -2.97M | 3.33M | -1.21M |
| Cash from Operations | -8.59M | -11.51M | -16.05M | -9.08M | -10.58M |
| Capital Expenditure | -439.00K | -240.00K | -110.00K | -149.00K | -186.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -3.89M | -174.00K | 19.00M | -11.71M | -62.04M |
| Cash from Investing | -4.33M | -414.00K | 18.89M | -11.86M | -62.23M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 598.00K | 26.49M | 44.00K | 53.00K | 29.83M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | 0.00 | -13.00K |
| Cash from Financing | 598.00K | 26.49M | 44.00K | 53.00K | 29.82M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -12.32M | 14.57M | 2.88M | -20.89M | -42.99M |